相关实验视频
Updated: May 5, 2026

The MPLEx Protocol for Multi-omic Analyses of Soil Samples
Published on: May 30, 2018
慢性Cr(VI) 暴露引起的生物毒性涉及Phoxinus lagowskii Dybowski的肝脏微生物群-肠轴干扰,基于多omics技术
Xinchi Shang1, Xinghua Che2, Kai Ma2
1Heilongjiang River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Harbin, 150070, China; College of Life Science, Northeast Agricultural University, Harbin, 150036, China.
六价 (Cr(VI)) 暴露会损害鱼肝和肠道微生物,破坏肠肝轴. 这项研究揭示了Cr(VI) 导致组织损伤,肠道失调和代谢障碍,影响鱼类的健康.
科学领域:
- 环境毒理学环境毒理学
- 鱼类生物学 鱼类生物学
- 微生物组研究 微生物组研究
背景情况:
- 六价 (Cr(VI)) 是一种有毒的工业污染物,对环境产生重大影响.
- 长期暴露于Cr6可以导致代谢障碍和组织损伤,但其对鱼肝和肠道微生物的影响还未得到充分研究.
- 肠肝轴在保持鱼的健康和恒温中起着至关重要的作用.
研究的目的:
- 阐明Cr(VI) 影响普通鱼肠肝轴的机制.
- 研究Cr(VI) 暴露对鱼类肝脏和肠道微生物群落的影响.
- 了解肠道失调,肝脏代谢和Cr (VI) 毒性之间的关系.
主要方法:
- 多原子分析 (代谢学,微生物组测序)
- 血清学检测试验 血清学检测试验
- 组织形态学检查 组织形态学检查
- 测量生理和生化指数测量
- 常见鱼暴露于对照剂,低剂量 (0.5 mg/L) 和高剂量 (2 mg/L) Cr (VI).
主要成果:
- 暴露于Cr (VI) 会导致严重的肝细胞损伤,肠缩和Cr (VI) 在剂量依赖的方式在组织中积累.
- 肠道微生物分析显示,有益细菌 (如Akkermansia) 的减少和有害细菌 (如Escherichia/Shigella) 的增加,这表明存在失能.
- 由于肠道损伤而增加的血脂多糖 (LPS) 水平加剧了肝脏代谢障碍,改变了关键代谢物并诱导了肝毒性.
结论:
- 慢性Cr(VI) 压力会破坏肠道微生物的平衡,并损害鱼肝中的脂肪酸和氨基酸代谢.
- 从肠道转移到肝脏的LPS扩大了Cr(VI) 诱导的肝毒性,突出了肝脏-微生物群-肠道轴作为一个关键的目标.
- 这项研究为鱼类肠肝系统中Cr (VI) 的毒理机制提供了新的见解,这对于环境风险评估至关重要.
更多相关视频
00:06Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
Published on: August 23, 2019
09:49Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
Published on: October 31, 2019
相关概念视频
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Risk factors
Microbial Bioremediation of Hydrocarbons
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Pancreatitis II: Pathophysiology